MRI-guided chemo before surgery for pancreatic cancer
Part of Cancer, Digestive system clinical trials.
This study tests whether using a special MRI scan to guide chemotherapy can help people with pancreatic cancer that is on the edge of being removable. The goal is to shrink the tumor enough for successful surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older.
- You have been newly diagnosed with borderline resectable pancreatic cancer (tumor that may be removable after treatment).
- You have not had any chemotherapy, radiation, or surgery for pancreatic cancer before.
- You are not pregnant, breastfeeding, or planning to become pregnant, and you are not planning to father a child during the study.
- You are able and willing to undergo MRI scans (no metal implants or other MRI safety issues).
- You have signed a consent form agreeing to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses MRI scans to see how well chemotherapy and radiation work in people with borderline resectable pancreatic cancer – a type where surgery might be possible but is risky. The goal is to find the best way to measure tumor response so doctors can make better treatment decisions.
This study tests a new, harmless “disposable” setup for MRI scans to measure how pancreatic cancer treatments affect the body. It may help doctors get more accurate MRI measurements, so treatment response can be assessed better.
This trial studies whether adding an MRI scan improves the selection of people with pancreatic cancer who may benefit from surgery. It focuses on patients without liver spread and with tumors that are borderline or likely removable.
This trial tests a way to give radiation therapy for pancreatic cancer using MRI scans to guide the treatment. It aims to make the radiation more precise and possibly more effective, and you will receive chemotherapy first, followed by radiation.
This study looks at MRI scans, computer-extracted imaging features, and blood/“liquid biopsy” tests after FOLFIRINOX chemotherapy to predict whether surgery can fully remove pancreatic cancer. It may help your care team choose the best next step—whether surgery is likely to be possible and how to plan it.
This trial studies using MRI scans to guide radiation therapy for locally advanced pancreas cancer or liver cancer. It may help make radiation planning more precise, either to control the cancer or to ease symptoms.
Hear when a new Borderline Resectable Pancreatic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.